Crossmark

Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder

Crossref DOI link: https://doi.org/10.1038/s41598-021-87840-5

Published Online: 2021-04-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lazary, Judit

Elemery, Monika

Dome, Peter

Kiss, Szilvia

Gonda, Xenia

Tombor, Laszlo

Pogany, Laszlo

Becskereki, Gergely

Toth, Blanka

Faludi, Gabor
Funding

Funding for this research was provided by:

Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (OTKA FK 131315)
License Information

Text and Data Mining valid from 2021-04-23

Version of Record valid from 2021-04-23
More Information

Article History

Received: 2 December 2020

Accepted: 31 March 2021

First Online: 23 April 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below